Assessment of Cu-ETS as a PET radiopharmaceutical for evaluation of regional renal perfusion
Abstract The copper(II) complex of ethylglyoxal bis(thiosemicarbazone) (Cu-ETS) was evaluated as a positron emission tomography (PET) radiopharmaceutical for assessment of regional renal perfusion. Methods The concordance of renal flow estimates obtained with 11- and 15-μm microspheres was confirmed...
Gespeichert in:
Veröffentlicht in: | Nuclear medicine and biology 2007-04, Vol.34 (3), p.247-255 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Abstract The copper(II) complex of ethylglyoxal bis(thiosemicarbazone) (Cu-ETS) was evaluated as a positron emission tomography (PET) radiopharmaceutical for assessment of regional renal perfusion. Methods The concordance of renal flow estimates obtained with 11- and 15-μm microspheres was confirmed in four immature farm pigs using co-injected46 Sc- and57 Co-microspheres administered into the left ventricle. With the use of both immature farm pigs ( n =3) and mature Göttingen minipigs ( n =6), regional renal radiocopper uptake following intravenous [64 Cu]Cu-ETS administration was compared to microsphere measurements of renal perfusion. The distribution and kinetics of [64 Cu]Cu-ETS were further studied by PET imaging of the kidneys. The rate of [64 Cu]Cu-ETS decomposition by blood was evaluated in vitro, employing octanol extraction to recover intact [64 Cu]Cu-ETS. Results The co-injected 11- and 15-μm microspheres provided similar estimates of renal flow. A linear relationship was observed between the renal uptake of intravenous [64 Cu]Cu-ETS and regional renal perfusion measured using microspheres. [64 Cu]Cu-ETS provided high-quality PET kidney images demonstrating the expected count gradient from high-flow outer cortex to low-flow medulla. When incubated with pig blood in vitro at 37°C, the [64 Cu]Cu-ETS radiopharmaceutical was observed to decompose with a half-time of 2.8 min. Conclusion Cu-ETS appears suitable for use as a PET radiopharmaceutical for evaluation of regional renal perfusion, affording renal uptake of radiocopper that varies linearly with microsphere perfusion measurements. Quantification of renal perfusion (in ml min−1 g−1 ) with [60,61,62,64 Cu]Cu-ETS will require correcting the arterial input function for the fraction of blood radiocopper remaining present as the intact Cu-ETS radiopharmaceutical, since the Cu-ETS chelate has limited chemical stability in blood. Rapid octanol extraction of blood samples appears suitable as an approach to capturing the actual blood concentration of [60/61/62/64 Cu]Cu-ETS. |
---|---|
ISSN: | 0969-8051 1872-9614 |
DOI: | 10.1016/j.nucmedbio.2007.01.002 |